Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.020
-0.005 (-0.25%)
At close: Aug 29, 2025, 4:00 PM
2.040
+0.020 (0.99%)
After-hours: Aug 29, 2025, 7:49 PM EDT

Daré Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
2727307015355
Upgrade
Market Cap Growth
-37.74%-10.87%-56.74%-54.05%178.42%240.92%
Upgrade
Enterprise Value
2522173110850
Upgrade
Last Close Price
2.023.123.719.9624.0016.08
Upgrade
PS Ratio
-1504.022774.4510.857.04--
Upgrade
PB Ratio
--4.51-6.036.343.95-47.78
Upgrade
P/TBV Ratio
---6.343.95-
Upgrade
P/FCF Ratio
-5.63----
Upgrade
P/OCF Ratio
-5.03----
Upgrade
EV/Sales Ratio
-2228.745.973.06--
Upgrade
EV/FCF Ratio
-4.52----
Upgrade
Debt / Equity Ratio
-0.24-0.22-0.280.040.01-0.66
Upgrade
Debt / FCF Ratio
-0.27----
Upgrade
Asset Turnover
-00.090.20--
Upgrade
Quick Ratio
0.270.740.561.153.290.67
Upgrade
Current Ratio
0.340.850.861.363.450.91
Upgrade
Return on Equity (ROE)
---994.69%-124.12%-205.82%-
Upgrade
Return on Assets (ROA)
-63.13%-67.57%-59.02%-39.38%-77.08%-228.45%
Upgrade
Return on Capital (ROIC)
---482.86%-77.49%-126.42%-4046.95%
Upgrade
Earnings Yield
-69.88%-14.93%-99.03%-43.96%-25.26%-49.80%
Upgrade
FCF Yield
-44.59%17.76%-129.65%-25.78%-18.79%-45.89%
Upgrade
Buyback Yield / Dilution
-10.12%-16.80%-3.23%-38.29%-103.23%-93.16%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q